Today: 20 May 2026
Allegro MicroSystems stock jumps 6% as February Analyst Day sharpens focus on targets
14 January 2026
1 min read

Allegro MicroSystems stock jumps 6% as February Analyst Day sharpens focus on targets

New York, Jan 14, 2026, 14:38 EST — Regular session

Allegro MicroSystems jumped 6.5% to $32.78 in afternoon trading Wednesday, beating a mixed pack of analog and power chipmakers. The boost came after the company announced it will hold an analyst day next month. Onsemi and Texas Instruments gained roughly 2.3% and 1.3%, respectively, while STMicroelectronics fell about 1.6%.

Analyst days serve as investor briefings that can shake up smaller chip companies, as executives typically detail strategy, product priorities, and long-term objectives. The timing is crucial for investors — these events happen right before the next quarterly report, when guidance can rapidly shift sentiment.

Chip stocks were mostly hit on Wednesday, with the Philadelphia Semiconductor Index falling roughly 1.7%, highlighting that Allegro’s rise was more of an isolated move than a trend across the sector.

Allegro announced its Analyst Day will take place on Feb. 18 at the Boston Marriott Long Wharf, from 9 a.m. to 1 p.m. Eastern. The event will be hybrid: a limited number of guests can attend in person by invitation, while others can join via a live webcast, the company said.

The company will release its third-quarter fiscal 2026 results before the market opens on Jan. 29. CEO Mike Doogue and CFO Derek D’Antilio are scheduled to discuss the earnings on a conference call at 8:30 a.m. ET, the firm announced earlier this month. Allegro specializes in power and sensing semiconductors for automotive, clean energy, and industrial automation sectors.

Investors want to hear about trends in auto and industrial orders, pricing, and customer inventory—details that carry more weight for analog and power chips than just this quarter’s headline. The Feb. 18 agenda brings another angle: the company plans to discuss its “target financial model,” a shorthand for the longer-term revenue and margin ranges it aims to achieve.

Analyst days can boost expectations ahead of earnings, too. If the guidance on Jan. 29 feels cautious, or Feb. 18 focuses more on broad themes than specific goals, the stock’s recent gains might reverse fast.

Jan. 29 brings the next big catalyst with results expected before the bell, followed by the Feb. 18 Analyst Day. Investors are keen to see if either event delivers updated financial targets or shifts in product strategy that might change the stock’s trajectory heading into February.

Stock Market Today

  • Stock Market Continues Modest Pullback as Leading Growth Stocks Hold
    May 19, 2026, 7:45 PM EDT. The stock market extended its losing streak to three sessions on Tuesday, marking a modest and orderly pullback. Despite the slump, leading growth stocks demonstrated resilience, showing signs of underlying strength amid broader market pressure. Investors are watching carefully as the overall market digests recent gains, while specific oil and gas companies attract attention for potential opportunities. This cautious environment suggests investors are balancing profit-taking with selective buying in sectors showing robust performance.

Latest articles

GCL Global Stock’s Wild After-Hours Jump: The $10 Million ADATA Deal Behind the Move

GCL Global Stock’s Wild After-Hours Jump: The $10 Million ADATA Deal Behind the Move

20 May 2026
GCL Global Holdings shares jumped to $1.00 after hours Tuesday, up 132%, following news that ADATA Technology invested another $10 million in its 4Divinity unit. The stock had closed regular trading at $0.43, below Nasdaq’s $1 minimum. Recent filings still warn of listing and execution risks. GCL reported first-half revenue up 94% to $98.7 million but posted a net loss of $5.6 million.
James Hardie Drops After Warning on Housing, Even With Q4 Beat

James Hardie Drops After Warning on Housing, Even With Q4 Beat

20 May 2026
James Hardie’s U.S.-listed shares dropped 6.1% Tuesday and slid another 2.6% after hours after reporting a 35% fall in quarterly net income to $28.5 million, despite a 45% jump in net sales to $1.40 billion. The company cited weak housing demand and warned the market remains uncertain. ASX shares had not traded post-earnings; they last closed at A$26.78, up 2.9%.
SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

20 May 2026
SELLAS Life Sciences shares rose 4.1% to $7.59 Tuesday after CEO Angelos Stergiou said its Phase 3 AML trial is two events from final analysis. The company reported $107.1 million in cash and a first-quarter net loss of $8.4 million. The REGAL trial’s main measure is overall survival. SELLAS remains blinded to results until the 80th event triggers data review.
Uber stock slips after NYC tipping report targets Uber Eats, as earnings date and new profit metrics loom
Previous Story

Uber stock slips after NYC tipping report targets Uber Eats, as earnings date and new profit metrics loom

Applied Digital stock slips after director flags share sale — what APLD investors watch next
Next Story

Applied Digital stock slips after director flags share sale — what APLD investors watch next

Go toTop